A roundup of some of the biggest healthcare and pharma news from China, including the country's struggle with a rampant COVID-19 outbreak and the…

A selection of the latest stories from Chinese pharma, including Novartis’ bet that the country will become its second biggest market by 2024…

The latest news from the Chinese pharmaceutical industry, including recent deals between domestic pharma giant Simcere and German biotech Vivoryon in…

While the vast majority of the global pharma market still comprises small molecule drugs, the biologics sector has grown rapidly since its inception…

The partnership between global pharma giant Eli Lilly and Chinese biotech Innovent Biologics, first initiated in March 2015, continues to bear…

On 30 April 2018, Hong Kong Stock Exchange’s (HKEX’s) introduced a number of reforms to allow and support the listing of pre-profit biotech…

A roundup of the latest news from Chinese biotechs, including a bumper IPO for Legend Biotech, a USD two million tie-up between Roche and Innovent…

The Chinese healthcare market has transformed dramatically in the past few years. There have been many reforms centred around the country’s vision…

Even though China’s pharmaceutical sector remains largely generics-based, the Middle Kingdom’s biotechnology scene has been flourishing in recent…

Dr Michael Yu, founder, Chairman and CEO of Innovent Biologics, one of China’s most successful and innovative biopharma start-up, shares his…